These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2253209)

  • 1. Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia.
    Nara N; Tohda S; Suzuki T; Nagata K; Yamashita Y; Imai Y; Maruyama Y; Tomiyama J
    Cancer Res; 1990 Dec; 50(23):7587-92. PubMed ID: 2253209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
    Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
    Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
    Nara N; Yamashita Y; Murohashi I; Tanikawa S; Imai Y; Aoki N
    Cancer Res; 1987 May; 47(9):2376-9. PubMed ID: 3471325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) by 30-minute infusion with acute nonlymphocytic leukemia--the possibility of administration for outpatients].
    Hirosawa S
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1991-3. PubMed ID: 3164182
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration].
    Noda T; Oku M; Kiyozuka Y; Maruyama M; Adachi S; Akada S; Okamura Y; Ichijo M
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2929-35. PubMed ID: 3178241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia.
    Nagata K; Tohda S; Suzuki T; Nara N
    Leukemia; 1989 Sep; 3(9):626-30. PubMed ID: 2761317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta).
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y
    Leukemia; 1989 Aug; 3(8):572-7. PubMed ID: 2473359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypoplastic leukemia--clinical effects of low-dose 4N-behenoyl-beta-D-arabinofuranosylcytosine (BH-AC) therapy].
    Nakada H; Takahashi I; Yorimitu S; Hara M; Ohmoto E; Inagaki T; Aoyama S; Nishimura M; Hayashi N; Sekito N
    Rinsho Ketsueki; 1987 Apr; 28(4):534-40. PubMed ID: 3476764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and pharmacokinetic studies of high dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Yoshida T; Nakamura S; Ohtake S; Ito K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1820-4. PubMed ID: 3592717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity of various human tumors to 1-beta-D-arabinofuranosylcytosine and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
    Chemotherapy; 1989; 35(3):181-6. PubMed ID: 2766858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia.
    Inatomi Y; Toyama K; Clark SC; Shimizu K; Miyauchi J
    Cancer Res; 1994 Jan; 54(2):455-62. PubMed ID: 7506123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of hematopoietic progenitors of acute myeloblastic leukemia to new compounds derived from marine organisms.
    Lishner M; Shur I; Bleiberg I; Rudi A; Kashman Y; Fabian I
    Leukemia; 1995 Sep; 9(9):1543-8. PubMed ID: 7658723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
    Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Oguro M; Takagi T
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):508-15. PubMed ID: 6764108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro growth patterns and drug sensitivities of leukemic blast progenitors among the subtypes of acute myelocytic leukemia.
    Nara N; Chen GJ; Murohashi I; Tohda S; Imai Y; Tomiyama J; Nagata K; Suzuki T; Tanikawa S; Shiina S
    Exp Hematol; 1992 Aug; 20(7):904-8. PubMed ID: 1628709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus.
    Nakamura K; Eizuru Y; Kumura K; Minamishima Y
    J Med Virol; 1990 Jun; 31(2):141-7. PubMed ID: 1696958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)].
    Sueyama H; Oguro M; Takagi T
    Rinsho Ketsueki; 1981 Jul; 22(7):1109-15. PubMed ID: 7328768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.